Educating Providers About Lung Screening

Lung Cancer Clinical Trial

Official title:

Educating Providers About Health Disparities in Lung Cancer Screening

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05064046
• Other study ID #: STUDY00003967
• Secondary ID: 3R01CA207228-05S
• Status: Completed
• Phase: N/A
• Start date: October 27, 2021
• Est. completion date: July 27, 2022

Study information

• Verified date: November 2021
• Source: Georgetown University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

We are conducting a randomized trial to compare the Health Disparities module to an existing provider module on lung cancer screening to evaluate the impact on primary care providers' knowledge, attitudes, and lung cancer screening referrals of African American and White patients.

Description:

We are conducting a randomized trial of two online, provider-facing education modules regarding lung cancer screening and smoking cessation. We will accrue 70 MedStar primary care providers (PCP). The baseline survey will incorporate items regarding lung cancer screening knowledge, providers' attitudes towards lung cancer screening, lung cancer screening ordering practices and provider characteristics. At the end of the baseline survey, PCPs will be randomly assigned to the LuCa + Health Disparities or LuCa only. PCPs will be asked to complete the intervention and the post-test within 1 week of randomization. The post test will cover knowledge of lung cancer screening, attitudes and opinions toward LCS. To assess PCP lung cancer screening ordering practices, we will review the MedConnect Electronic Health Record (EHR) to compare the two study groups post-randomization on the number of orders made for LCS.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 77
• Est. completion date: July 27, 2022
• Est. primary completion date: February 28, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• MedStar provider (attending or resident physician, physician's assistant, or nurse practitioner)

• English speaking

• ability to provide meaningful consent

• ability to provide last two digits of NPI.

Exclusion Criteria:

• N/A

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Intervention

Behavioral:
• LuCa + Health Disparity module
The Health Disparity course will review disparities in the burden of lung cancer across racial/ethnic groups, discuss differences in smoking patterns and use of evidence-based smoking cessation, and describe emerging disparities in lung cancer screening. The course will also offer resources for providers to address common barriers to screening among underserved/underrepresented groups, including insurance information, transportation options, procedure time, and patient navigation assistance. Lesson 1 of the LuCa online course addresses lung cancer screening and shared decision making.

Locations

Country	Name	City	State
United States	MedStar Health Georgetown University Hospital	Washington	District of Columbia

Sponsors (2)

Lead Sponsor	Collaborator
Georgetown University	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of providers with improved mean lung cancer screening knowledge score	Knowledge about lung cancer screening	1 week
Primary	Number of providers with improved mean attitudes score	Attitudes about lung cancer screening	1 week
Secondary	Rate of lung cancer screening referrals	Lung cancer screening referrals from the electronic health record	2 months post-randomization